Higher throughput human hepatocyte assays for the evaluation of time-dependent inhibition of CYP3A4.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Drug Metabolism Letters

• Publication date

  2011-07-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/187231211796904964PMID 21722087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Development of In Silico Models for Predicting Potential Time-Dependent Inhibitors of Cytochrome P450 3A4.

  2022cites this paper
• Rational Design of a Two-Photon Fluorescent Probe for Human Cytochrome P450 3A and the Visualization of Mechanism-Based Inactivation.

  2021cites this paper
• Development and Validation of a Higher-Throughput Cytochrome P450 Inhibition Assay with the Novel Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Human Hepatocytes)

  2019cites this paper
• Structural Perspectives of the CYP3A Family and Their Small Molecule Modulators in Drug Metabolism.

  2019cites this paper
• A Novel In Vitro Experimental System for the Evaluation of Drug Metabolism: Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Cryopreserved Human Hepatocytes)

  2018cites this paper
• 1-Aminobenzotriazole: A Mechanism-Based Cytochrome P450 Inhibitor and Probe of Cytochrome P450 Biology

  2018cites this paper
• Synthesis and mechanistic evaluation of novel N'-benzylidene-carbohydrazide-1H-pyrazolo[3,4-b]pyridine derivatives as non-anionic antiplatelet agents.

  2017cites this paper
• DMD066902 162..171

  2016influential citation
• Hepatocyte-Based Metabolism, Drug–Drug Interaction, and Toxicity Assays in Drug Discovery and Drug Development to Minimize Attrition

  2015cites this paper
• Pharmacokinetic Interactions between Drugs and Botanical Dietary Supplements

  2015influential citation
• Evaluation of Adverse Drug Properties with Cryopreserved Human Hepatocytes and the Integrated Discrete Multiple Organ Co-culture (IdMOCTM) System

  2015cites this paper
• Cytochrome P450 time-dependent inhibition and induction: advances in assays, risk analysis and modelling

  2015cites this paper
• In Vitro Approaches to Study Drug–Drug Interactions

  2014cites this paper
• Biomarkers and human hepatocytes.

  2014cites this paper
• In vitro human hepatocyte-based experimental systems for the evaluation of human drug metabolism, drug-drug interactions, and drug toxicity in drug development.

  2014influential citation
• Bioluminescent assays for ADME evaluation: dialing in CYP selectivity with luminogenic substrates

  2012influential citation
• Time-Dependent Inhibition and Estimation of CYP3A Clinical Pharmacokinetic Drug-Drug Interactions Using Plated Human Cell Systems

  2012cites this paper
• Time-Dependent Inhibition and Estimation of CYP3A Clinical Pharmacokinetic Drug-Drug Interactions Using Plated Human Cell Systems

  2012cites this paper
• Molecular imaging of cytochrome P450 activity in mice.

  2012cites this paper
• Critical Human Hepatocyte-Based In Vitro Assays for the Evaluation of Adverse Drug Effects

  2011cites this paper